Volastra Therapeutics Company

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Technology: Tumor-Specific Antigens
Industry: Tumor-Specific Antigens
Headquarters: New York, New York, United States
Founded Date: 2019-01-01
Employees Number: 51-100
Funding Status: Seed
Investors Number: 12
Total Funding: 44000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-04-06
Last Funding Type: Seed

Visit Website
Register and Claim Ownership